Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1806-1811

  Van Rij, Ronald P ^b   De Roda Husman, Ana Maria ^b   Brouwer, Margreet ^b   Goudsmit, Jaap ^b   Coutinho, Roel A ^b   Schuitemaker, Hanneke ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ARTICLE; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; SURVIVAL; SYNCYTIUM;

CELLS, CULTURED; CONFIDENCE INTERVALS; DISEASE PROGRESSION; GENOTYPE; GIANT CELLS; HIV SEROPOSITIVITY; HIV-1; HOMOSEXUALITY, MALE; HUMANS; ISOLEUCINE; LEUKOCYTES, MONONUCLEAR; MALE; POINT MUTATION; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; TIME FACTORS; VALINE; VARIATION (GENETICS);

EID: 0031737178     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314522     Document Type: Article

References (15)

1. De Roda Husman AM, Schuitemaker H. Chemokine receptors and the clinical course of HIV-1 infection. Trends Microbiol 1998;6:244-9.
2. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med 1996;2:1293-300.
3. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
4. De Roda Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-90.
5. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
6. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998;4:350-3.
7. Rizzardi GP, Morawetz RA, Vicenzi E, et al. CCR2 polymorphism and HIV disease. Nat Med 1998;4:252-3.
8. Van Griensven GJP, De Vroome EMM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br Med J 1989;298:218-21.
9. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
10. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl):1S-15S.
11. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1993;41(RR-17):1-19.
12. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-8.
13. Scarlatti G, Tresoldi E, Björndal Å, et al. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine mediated suppression. Nat Med 1997;3:1259-65.
14. Guignard F, Combadiere C, Tiffany HL, Murphy PM. Gene organisation and promoter function for CC chemokine receptor 5 (CCR5). J Immunol 1998;160:985-92.
15. Mummidi S, Ahuja SS, McDaniel BL, Ahuja SK. The human CC chemokine receptor 5 (CCR5) gene, multiple transcripts with 5′-end heterogeneity, dual promotor usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 1998;272:30662-71.